Stocktoria

RELMADA THERAPEUTICS, INC. RLMD

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-03-03 · LEI

RELMADA THERAPEUTICS, INC. statistics & valuation

Market cap$701.7M
P / B8.1×
Return on equity-66.3%
Return on capital-67.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2017201820192019202020212022202320242025
Operating margin (%)
2017201820192019202020212022202320242025
Return on equity (%)
-430.50% -227.50% -13.00% -56.30% -60.40% -111.80% -115.70% -225.20% -66.30% 2017201820192019202020212022202320242025
Shares outstanding
12.5M 12.5M 9.7M 14.5M 16.3M 27.7M 30.1M 30.1M 30.2M 73.3M 2017201820192019202020212022202320242025
Net debt ($)
2017201820192019202020212022202320242025
Share buybacks ($)
2017201820192019202020212022202320242025
Return on assets (%)
-221.60% -294.00% -169.50% -12.80% -50.30% -56.30% -102.70% -101.30% -174.60% -61.00% 2017201820192019202020212022202320242025
Free cash flow margin (%)
2017201820192019202020212022202320242025
Debt / equity (×)
2017201820192019202020212022202320242025
EPS ($)
-$7.16 -$5.30 -$3.28 -$2.65 -$1.45 2017201820192019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2019FY2018FY2017
Return on assets-61.0%-174.6%-101.3%-102.7%-56.3%-50.3%-12.8%-169.5%-294.0%-221.6%
Return on equity-66.3%-225.2%-115.7%-111.8%-60.4%-56.3%-13.0%-227.5%162.5%-430.5%
Current ratio14.624.458.0012.2614.839.3780.213.830.461.80

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.